Parkinson's UK is the leading UK charity for Parkinson's research and support. Founded in 1969 as the Parkinson's Disease Society, the organization has invested over £85 million in research to find better treatments and ultimately a cure for Parkinson's disease[1]. The charity supports people living with Parkinson's across the UK through a network of local branches, specialist nurses, and information resources.
Parkinson's UK plays a crucial role in the Parkinson's research ecosystem, funding cutting-edge research into the understanding of Parkinson's, development of new treatments, and clinical trials. The organization also advocates for people with Parkinson's and their families, working to improve care and services nationwide.
A nationwide network of research centers and experts collaborating on Parkinson's research. The network includes:
Parkinson's UK funds a portfolio of drug discovery projects
For more information about the Drug Club repurposing program, see Parkinson's UK Drug Club.
For an overview of all major PD drug repurposing consortia, see Parkinson's Disease Drug Repurposing Consortia. targeting:
The charity partners with:
The charity funds specialist Parkinson's nurses who provide:
Over 300 local branches across the UK provide:
Parkinson's UK advocates for:
A public awareness campaign highlighting the diverse impact of Parkinson's beyond motor symptoms.
Parkinson's UK research investment has yielded significant scientific outcomes:
The organization's work has directly improved quality of life for people with Parkinson's:
Parkinson's UK maintains substantial research expenditure:
The current research strategy emphasizes:
Parkinson's UK is governed by a board of trustees with expertise in:
An expert scientific advisory board reviews research funding decisions, ensuring:
The organization engages thousands of volunteers:
Parkinson's UK incorporates patient voices in research:
Current frontier research includes:
The charity supports innovative approaches: